Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Taipei Medical University WanFang Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
At present, the families of cancer patients are lack knowledge and experience of nutritional care after discharge. As a result, cancer patients often suffer from low nutritional status after being discharged from the hospital.
This study intends to design a home nutrition care plan to explore the effect of a home nutrition care plan on the nutritional status of patients with liver cancer and colorectal cancer at risk of malnutrition. Malnutrition or side effects often lead to natural food intake for patients. It is not enough to meet the nutritional requirements, so it is matched with dietary products to help patients more easily meet their nutritional requirements. Supplements are used to alleviate patients' side effects. It is hoped that they can help patients improve their nutritional status.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control group | Active Comparator |
|
|
| Nutrition care plan group A | Experimental |
3.The nutrition care plan period will be three months. |
|
| Nutrition care plan group B | Experimental |
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nutritional consultant | Behavioral | The control group is to be consulted by the dietitian using communication software (Line) or telephone to evaluate the nutritional requirement and guide the cancer diet principles before starting the project. |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluate nutritional status indicators change | Improvement of nutritional status indicators: Abridged Patient-Generated Subjective Global Assessment (aPG-SGA) assessment scores. | Baseline and at 0.5th month |
| Evaluate nutritional status indicators change | Improvement of nutritional status indicators: Abridged Patient-Generated Subjective Global Assessment (aPG-SGA) assessment scores. | Baseline and at 1st month |
| Evaluate nutritional status indicators change | Improvement of nutritional status indicators: Abridged Patient-Generated Subjective Global Assessment (aPG-SGA) assessment scores. | Baseline and at 1.5th month |
| Evaluate nutritional status indicators change | Improvement of nutritional status indicators: Abridged Patient-Generated Subjective Global Assessment (aPG-SGA) assessment scores. | Baseline and at 2nd month |
| Evaluate nutritional status indicators change | Improvement of nutritional status indicators: Abridged Patient-Generated Subjective Global Assessment (aPG-SGA) assessment scores. | Baseline and at 2.5th month |
| Evaluate nutritional status indicators change | Improvement of nutritional status indicators: Abridged Patient-Generated Subjective Global Assessment (aPG-SGA) assessment scores. | Baseline and at third month |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluate anthropometric measurements change-Body weight | Weight in kilograms | Baseline and at 0.5th, 1st, 1.5th, 2nd, 2.5th, and third month |
| Evaluate anthropometric measurements change-Body mass index(BMI) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Taipei Medical University | Taipei | 110 | Taiwan |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Nutritional consultant + High-calorie, high-protein liquid nutrition supplement | Dietary Supplement | At the beginning of the plan, the dietitian first calculates the patient's daily calorie intake and the ratio of the three macronutrients and guides the patients or their family members of the nutritional care plan group A to implement a daily diet with a concentrated high-calorie and high-protein liquid supplement (Commercial formula contains 425 kcal and 19.1 grams of protein). |
|
| Nutritional consultant + Liquid supplement + Powdered supplement 1 and 2 | Combination Product | At the beginning of the plan, the dietitian first calculates the patient's daily calorie intake and the ratio of the three macronutrients and guides the patients or their family members of the nutritional care plan group B to implement a daily diet with a concentrated high-calorie and high-protein liquid supplement (Commercial formula contains 425 kcal and 19.1 grams of protein). Meanwhile, nutrition care plan group B will be given powdered supplement 1 (containing β-glucan and gamma-aminobutyric acid) and nutritional products and powdered supplement 2 (contains water-soluble dietary fiber and probiotics). |
|
Weight and height will be combined to report BMI in kg/m^2
| Baseline and at 0.5th, 1st, 1.5th, 2nd, 2.5th, and third month |
| Evaluate biochemical data change-White blood cells (WBC) | White blood cells (x10^3/ul) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-Red blood cells (RBC) | Red blood cells (x10^6/ul) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-Hemoglobin (Hb) | Hemoglobin (g/dl) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-Hematocrit (Hct) | Hematocrit (%) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-Platelet | Platelet (x10^3/ul) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-Mean corpuscular volume (MCV) | Mean corpuscular volume (fl) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-Mean corpuscular hemoglobin (MCH) | Mean corpuscular hemoglobin (pg) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-Mean corpuscular hemoglobin concentration (MCHC) | Mean corpuscular hemoglobin concentration (g/dl) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-Neutrophil band | Neutrophils (%), Lymphocyte (%), Monocyte (%), Eosinophil (%), and Basophil (%) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-renal function | Blood urea nitrogen and Creatinine (mg/dl) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-Albumin (Alb) | Albumin (g/dl) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-liver function | Aspartate aminotransferase and Alanine aminotransferase (U/l) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-renal function | estimated Glomerular filtration rate (eGFR) (mL/min/1.73 m^2) | Baseline and at 1st, 2nd, and third month |
| Evaluate biochemical data change-lipid profile | Triglyceride, Total cholesterol, Low-density lipoprotein cholesterol, High-density lipoprotein cholesterol (mg/dl) | Baseline and third month |
| Evaluate food intake change (energy) | Use 24-hour dietary recall to evaluate the nutrition intake (energy in calories) | Baseline and at 0.5th, 1st, 1.5th, 2nd, 2.5th, and third month |
| Evaluate food intake change (protein) | Use 24-hour dietary recall to evaluate the nutrition intake (protein in grams) | Baseline and at 0.5th, 1st, 1.5th, 2nd, 2.5th, and third month |
| Evaluate quality of life indicators change | Scores on the Quality of Life Scale (European Organization for Research and Treatment of Cancer quality of life questionnaires core 30, EORTC QLQ-C30) | Baseline and at 0.5th, 1st, 1.5th, 2nd, 2.5th, and third month |
| ID | Term |
|---|---|
| D044342 | Malnutrition |
| D003110 | Colonic Neoplasms |
| D008113 | Liver Neoplasms |
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D008107 | Liver Diseases |
| D012002 | Rectal Diseases |
Not provided
Not provided